• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessment of risk factors for increased resource utilization in kidney transplantation.肾移植中资源利用增加的风险因素评估。
J Surg Res. 2018 Feb;222:195-202.e2. doi: 10.1016/j.jss.2017.09.037.
2
Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients.肾移植受者药物相关问题预测模型的开发
Pharmacotherapy. 2017 Feb;37(2):159-169. doi: 10.1002/phar.1886. Epub 2017 Feb 3.
3
Hospital admissions and emergency department visits among kidney transplant recipients.肾移植受者的住院和急诊就诊情况。
Clin Transplant. 2019 May;33(5):e13522. doi: 10.1111/ctr.13522. Epub 2019 Apr 4.
4
Resource utilization among kidney transplant recipients.肾移植受者的资源利用情况。
Kidney Int. 2003 Aug;64(2):657-64. doi: 10.1046/j.1523-1755.2003.00102.x.
5
Nephrologists' management of patient medications in kidney transplantation: results of an online survey.肾脏移植中肾病学家对患者药物的管理:一项在线调查结果
J Eval Clin Pract. 2015 Oct;21(5):879-85. doi: 10.1111/jep.12394. Epub 2015 Jun 17.
6
Healthcare utilization and costs with fixed-source versus variable-source tacrolimus in patients receiving a kidney transplant.肾移植患者中使用固定来源与可变来源他克莫司的医疗保健利用情况及费用
J Med Econ. 2018 Nov;21(11):1067-1074. doi: 10.1080/13696998.2018.1503596. Epub 2018 Aug 14.
7
Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety: A Randomized Controlled Clinical Trial.药师主导的移动医疗干预和移植药物安全:一项随机对照临床试验。
Clin J Am Soc Nephrol. 2021 May 8;16(5):776-784. doi: 10.2215/CJN.15911020. Epub 2021 Apr 30.
8
Adherence in patients in the first year after kidney transplantation and its impact on graft loss and mortality: a cross-sectional and prospective study.肾移植术后第一年患者的依从性及其对移植肾丢失和死亡率的影响:一项横断面和前瞻性研究。
J Adv Nurs. 2014 Dec;70(12):2871-83. doi: 10.1111/jan.12447. Epub 2014 May 22.
9
Emergency Department Visits after Kidney Transplantation.肾移植后的急诊科就诊情况。
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):674-83. doi: 10.2215/CJN.07950715. Epub 2016 Mar 24.
10
Achieving blood pressure control among renal transplant recipients by integrating electronic health technology and clinical pharmacy services.通过整合电子健康技术和临床药学服务实现肾移植受者的血压控制。
Am J Health Syst Pharm. 2015 Nov 15;72(22):1987-92. doi: 10.2146/ajhp140810.

引用本文的文献

1
A pharmacist-led intervention to improve kidney transplant recipient outcomes and identify patients at risk of highly variable trough tacrolimus levels: a cohort study.药师主导的干预措施改善肾移植受者结局并识别具有他克莫司浓度变异性高风险的患者:一项队列研究。
Eur J Hosp Pharm. 2024 Jun 21;31(4):314-320. doi: 10.1136/ejhpharm-2022-003625.
2
Evaluation of medication-related problems in liver transplant recipients with and without an outpatient medication consultation by a clinical pharmacist: a cohort study.评价临床药师开展门诊用药咨询前后肝移植受者的药物相关问题:一项队列研究。
Int J Clin Pharm. 2022 Oct;44(5):1114-1122. doi: 10.1007/s11096-022-01423-6. Epub 2022 Sep 13.
3
Pharmacist-Led, Technology-Assisted Study to Improve Medication Safety, Cardiovascular Risk Factor Control, and Racial Disparities in Kidney Transplant Recipients.由药剂师主导、技术辅助的研究,旨在改善肾移植受者的用药安全、心血管危险因素控制及种族差异。
J Am Coll Clin Pharm. 2018 Dec;1(2):81-88. doi: 10.1002/jac5.1024. Epub 2018 Jun 21.

本文引用的文献

1
Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients.肾移植受者药物相关问题预测模型的开发
Pharmacotherapy. 2017 Feb;37(2):159-169. doi: 10.1002/phar.1886. Epub 2017 Feb 3.
2
Emergency Department Visits after Kidney Transplantation.肾移植后的急诊科就诊情况。
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):674-83. doi: 10.2215/CJN.07950715. Epub 2016 Mar 24.
3
Recipient Criteria Predictive of Graft Failure in Kidney Transplantation.预测肾移植中移植物失败的受者标准
Int J Angiol. 2016 Mar;25(1):29-38. doi: 10.1055/s-0035-1563605. Epub 2015 Sep 15.
4
Development of an aggregated system for classifying causes of drug-related problems.用于对药物相关问题的原因进行分类的综合系统的开发。
Ann Pharmacother. 2015 Apr;49(4):405-18. doi: 10.1177/1060028014568008. Epub 2015 Jan 22.
5
Clinical and economic outcomes associated with medication errors in kidney transplantation.肾移植中与用药错误相关的临床和经济结果。
Clin J Am Soc Nephrol. 2014 May;9(5):960-6. doi: 10.2215/CJN.09300913. Epub 2014 Apr 24.
6
Early hospital readmission after kidney transplantation: patient and center-level associations.肾移植术后早期医院再入院:患者和中心层面的关联。
Am J Transplant. 2012 Dec;12(12):3283-8. doi: 10.1111/j.1600-6143.2012.04285.x. Epub 2012 Sep 27.
7
Predictive validity of a medication adherence measure in an outpatient setting.门诊环境中药物依从性测量的预测效度。
J Clin Hypertens (Greenwich). 2008 May;10(5):348-54. doi: 10.1111/j.1751-7176.2008.07572.x.
8
Medication errors in the outpatient setting: classification and root cause analysis.门诊环境中的用药错误:分类与根本原因分析
Arch Surg. 2007 Mar;142(3):278-83; discussion 284. doi: 10.1001/archsurg.142.3.278.
9
Comorbid conditions in kidney transplantation: association with graft and patient survival.肾移植中的合并症:与移植物及患者生存的关联
J Am Soc Nephrol. 2005 Nov;16(11):3437-44. doi: 10.1681/ASN.2005040439. Epub 2005 Sep 21.
10
Resource utilization among kidney transplant recipients.肾移植受者的资源利用情况。
Kidney Int. 2003 Aug;64(2):657-64. doi: 10.1046/j.1523-1755.2003.00102.x.

肾移植中资源利用增加的风险因素评估。

Assessment of risk factors for increased resource utilization in kidney transplantation.

作者信息

Vranian Steven Craig, Covert Kelly L, Mardis Caitlin R, McGillicuddy John W, Chavin Kenneth D, Dubay Derek, Taber David J

机构信息

Division of Transplant Surgery, Medical University of South Carolina, Charleston, South Carolina.

College of Pharmacy, Bill Gatton College of Pharmacy, Johnson City, Tennessee.

出版信息

J Surg Res. 2018 Feb;222:195-202.e2. doi: 10.1016/j.jss.2017.09.037.

DOI:10.1016/j.jss.2017.09.037
PMID:29100587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5742052/
Abstract

BACKGROUND

There are only a limited number of studies that have sought to identify patients at high risk for medication errors and subsequent adverse clinical outcomes. This study sought to identify risk factors for increased health care resource utilization in kidney transplant recipients based on drug-related problems and self-administered surveys.

METHODS

In this prospective observational study, adult kidney transplant recipients seen in the transplant clinic between September and November 2015 were surveyed for self-reported demographics, medication adherence, and health status/outlook. Subsequently, patients were assessed for associations between survey results, pharmacist-derived drug-related problems, and health resource utilization over a minimum 6-mo follow-up period. Based on univariate associations, two risk cohorts were identified and compared for health care utilization using multivariable Poisson regression.

RESULTS

A total of 237 patients were included, with a mean follow-up of 8 mo. From the patient survey data, Medicaid insured or self-rated poor health status were identified as a significant risk cohort. From pharmacist assessments, those who received incorrect medication or lacked appropriate follow-up medication monitoring were identified as a significant risk cohort (pharmacy errors). The Medicaid insured or self-rated poor health status cohort experienced 43% more total health care encounters (incident rate ratios [IRR] 1.43, 1.01-2.02) and 35% more transplant clinic visits (IRR 1.35, 1.03-1.77). The pharmacy errors cohort experienced 4.2 times the rate of total health care encounters (IRR 4.17, 1.55-11.2), 4.1 times the rate of hospital readmissions (IRR 4.09, 1.58-10.6), and 2.3 times the rate of transplant clinic visits (IRR 2.31, 1.04-5.11).

CONCLUSIONS

Medicaid insurance, self-rated poor health status, and errors in the medication regimen or monitoring were significant risk factors for increased health care utilization in kidney transplant recipients. Further research is warranted to validate these potential risk factors, determine the long-term impact on graft/patient survival, and assess the mutability of these risks through prospective identification and intervention.

摘要

背景

仅有少数研究试图确定用药错误及随后不良临床结局的高风险患者。本研究旨在基于药物相关问题和自我管理调查确定肾移植受者医疗资源利用增加的风险因素。

方法

在这项前瞻性观察研究中,对2015年9月至11月在移植诊所就诊的成年肾移植受者进行了自我报告的人口统计学、用药依从性及健康状况/前景的调查。随后,在至少6个月的随访期内评估患者的调查结果、药剂师发现的药物相关问题与医疗资源利用之间的关联。基于单变量关联,确定了两个风险队列,并使用多变量泊松回归比较了它们的医疗利用情况。

结果

共纳入237例患者,平均随访8个月。从患者调查数据中,医疗补助保险参保者或自我评定健康状况差被确定为一个显著风险队列。从药剂师评估中,接受错误药物治疗或缺乏适当随访药物监测的患者被确定为一个显著风险队列(药房错误)。医疗补助保险参保者或自我评定健康状况差的队列总医疗就诊次数多43%(发病率比[IRR]1.43,1.01 - 2.02),移植诊所就诊次数多35%(IRR 1.35,1.03 - 1.77)。药房错误队列的总医疗就诊率是4.2倍(IRR 4.17,1.55 - 11.2),医院再入院率是4.1倍(IRR 4.09,1.58 - 10.6),移植诊所就诊率是2.3倍(IRR 2.31,1.04 - 5.11)。

结论

医疗补助保险、自我评定健康状况差以及药物治疗方案或监测中的错误是肾移植受者医疗利用增加的显著风险因素。有必要进行进一步研究以验证这些潜在风险因素,确定其对移植物/患者存活的长期影响,并通过前瞻性识别和干预评估这些风险的可变性。